Terms ending in 2037
Every in-force patent on Ablynx N.V.'s record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,553,901 | Methods for Detecting And/Or Measuring Anti-Drug Antibodies, in Particular Treatment-Emergent Anti-Drug Antibodies In force · Medium confidence | Ablynx N.V. | In force | Medium confidence | |
| US 11,009,511 | Methods for Detecting And/Or Measuring Anti-Drug Antibodies, in Particular Treatment-Emergent Anti-Drug Antibodies In force · High confidence | Ablynx N.V. | In force | High confidence | |
| US 10,975,141 | Method for the Production of Immunoglobulin Single Variable Domains In force · High confidence | Ablynx N.V. | In force | High confidence | |
| US 11,851,480 | Method for the Production of Immunoglobulin Single Variable Domains In force · Medium confidence | Ablynx N.V. | In force | Medium confidence | |
| US 11,919,966 | Methods for Inhibiting Tumor Growth or Treating Cancer by Administering an Immunoglobulin Single Variable Domain That Binds Glucocorticoid-Induced TNFR Family-Related Receptor (GITR) In force · High confidence | Ablynx N.V. | In force | High confidence | |
| US 11,753,465 | Nucleic Acids Encoding Polypeptides Against IL-23 In force · High confidence | Sanofi | In force | High confidence | |
| US 10,927,186 | T Cell Recruiting Polypeptides Based on TCR Alpha/Beta Reactivity In force · High confidence | Ablynx N.V. | In force | High confidence | |
| US 12,698,329 | T Cell Recruiting Polypeptides Capable of Binding CD123 and TCR Alpha/Beta In force · Medium confidence | Ablynx N.V. | In force | Medium confidence | |
| US 12,662,527 | Improved Serum Albumin Binding Immunoglobulin Single Variable Domains In force · High confidence | Sanofi | In force | High confidence |
9 of 9 patents shown. Soonest term end first, then patent number.
7 of these are in force and held by Ablynx N.V..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.